VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NEO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NEONeoGenomics, Inc.
$15.29$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNEOCash Flow

NeoGenomics, Inc. (NEO) Cash Flow Statement

26Y historyFree accessUpdated daily

Free cash flow oscillated around breakeven, reaching -$20.7M in 2026Q3 after $11.7M in 2026Q2, with working capital drains of -$28.0M in the latest quarter weighing on cash conversion.

Income StatementBalance SheetCash FlowRatios

NEO Cash Flow Statement

Annual statement

NEO Cash Flow Statement

NeoGenomics, Inc. (NEO) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash from Operations4.28M5.23M7.02M-1.95M-65.99M-26.72M1.46M23.37M44.79M18.04M21.48M6.39M9.45M2.23M-492K69K-2.05M-1.5M-138.31K-2.64M-693.78K-902.05K-658.13K-532.37K-384.8K-77.41K-177.13K
Operating CF Margin %-0.72%1.06%-0.33%-12.95%-5.52%0.33%5.72%16.18%7.51%8.8%6.41%10.85%3.35%-0.82%0.16%-5.97%-5.09%-0.69%-22.97%-10.71%-47.85%-117.93%-143.89%-411.59%-7740.7%-70.18%
Operating CF Growth %-220.26%-25.53%459.6%97.04%-146.95%-1930.34%-93.75%-47.82%148.3%-16.02%235.95%-32.35%324.34%552.64%-813.04%103.36%-36.76%-984.85%94.77%-280.9%23.09%-37.06%-23.62%-38.35%-397.11%56.3%-
Net Income-32.3M-108.03M-78.73M-87.97M-144.25M-8.35M4.17M8.01M2.64M-846K-5.72M-2.54M1.13M2.03M65K-1.18M-3.3M-2.24M-1.38M-3.38M-129.66K-997.16K-818.99K-535.76K-590.52K-8.08M-970.28K
Depreciation & Amortization65.21M67.82M72.55M72.58M69.43M53.35M35.72M30.27M21.73M22.59M23.21M7.14M5.64M4.41M3.82M2.08M1.78M1.18M740.56K506.36K306.59K181.07K104.26K48.04K-207.31K245.67K26.4K
Stock-Based Compensation26.69M41.32M33.41M24.63M24.67M22.46M10.21M10M6.96M6.44M5.44M3.48M692K929K798K458K411K372.95K246.18K00000000
Deferred Taxes-1.35M000-16.1M0951K1.49M404K19.96M15.32M-2.07M2.44M2.8M3.05M049K68.65K254.01K00000000
Other Non-Cash Items12.86M36.21M12.42M14.29M31.95M-89.59M12.15M6.03M542K440K4.6M2.32M66K49K38K2.61M2.46M2.22M1.93M1.41M628.84K298.09K35.18K46.72K236.3K7.74M195.24K
Working Capital Changes-66.83M-32.09M-32.63M-25.49M-31.7M-4.6M-61.75M-32.42M12.51M-30.55M-21.36M-1.95M-517K-7.99M-8.26M-3.9M-3.45M-3.11M-1.93M-1.18M-1.5M-384.04K21.41K-91.36K176.74K13.39K571.51K
Change in Receivables-58.38M-6.18M-19.31M-11.52M-7.58M-4.69M-12.6M-17.3M209K-24.24M-18.43M-3.21M-2.77M-7.42M-9.19M-5.23M-2.86M-3.87M-1.47M00000000
Change in Inventory3.04M-1.54M-2.7M-454K-1.1M1.63M-15.2M-5.75M734K-1.42M-1.15M-896K-229K-442K-657K-315K-285K-110.34K-186.71K-187.39K-57.36K-44.88K-4.53K8.71K-19.31K00
Change in Payables-6.58M-4.69M-4M-4.55M2.79M19.32M-3.97M-9M12.92M-4.54M-2.1M5.9M2.47M868K1.44M000000000000
Cash from Investing-31.47M-12.34M12.86M76.71M517K-632.37M-159.44M-19.63M-139.69M-13.69M-6.5M-75.16M-9.6M-2.01M-3.65M-897K-916K-963.74K-501.78K-716.14K-398.62K-117.63K-85.93K-63.19K-418K-2.69K0
Capital Expenditures-32.86M-27.01M-41.06M-28.75M-30.89M-64.14M-29.1M-20.03M-14.31M-13.69M-7.54M-2.21M-3.77M-2.01M-3.65M-897K-916K-963.74K-501.78K-516.14K-398.62K-117.63K-85.93K-63.19K-418K-2.9K0
CapEx % of Revenue4.17%3.71%6.22%4.86%6.06%13.24%6.55%4.9%5.17%5.7%3.09%2.22%4.33%3.03%6.1%2.06%2.67%3.27%2.51%4.49%6.16%6.24%15.4%17.08%447.1%290%-
Acquisitions0-6.45M000-419.4M-37M399K-125.38M01.03M-72.94M-5.83M00000000000000
Investments---------------------------
Other Investing1.47M1.57M0012.1M-15M00001.03M-72.94M-9.6B-2.01M-1.04M-897M-916M-963.74K0-200K000002090
Cash from Financing2.32M-200.29M4.65M4.55M11.83M725.28M235.6M159.47M91.96M-4.09M-25.87M58.49M29.01M2.75M3.38M2.36M2.43M3.63M897.68K3.44M1.21M918.08K831.56K620.61K725.58K157.31K133.7K
Debt Issued (Net)16.87M-201.25M0-70K-758K334.41M91.31M-12.51M5.1M-6.68M27.56M60.91M-7.86M-2.61M2.37M-1.12M1.75M-1.13M837.21K-168.48K118.02K00000-5.87K
Equity Issued (Net)-5.55M962K4.65M4.62M12.59M423.21M147.6M171.98M94M2.59M-51.23M034.25M003.48M180K5.76M60.48K5.29M1.09M211.66K740.23K00025K
Dividends Paid000000000000000000000000000
Share Repurchases-22.69M0000000-50.1M0-55M0000000000000000
Other Financing-8.99M0000-32.34M-3.32M0-7.14M0-2.2M-2.42M2.62M5.36M1.01M0500K-1M0-1.68M0706.41K91.33K620.61K725.58K157.31K114.57K
Net Change in Cash-24.84M-207.39M24.52M79.31M-53.65M66.19M77.62M163.21M-3.01M296K-10.89M-10.27M28.86M2.97M-760K1.53M-534K1.16M257.6K84.31K115.32K-101.6K87.5K25.05K-77.22K77.22K-43.43K
Free Cash Flow-28.58M-21.78M-34.04M-30.7M-96.88M-90.86M-27.64M3.34M30.48M4.35M13.94M4.18M5.68M216K-4.14M-828K-2.97M-2.46M-640.09K-3.16M-1.09M-1.02M-744.07K-595.55K-802.79K-80.31K-177.13K
FCF Margin %-3.63%-2.99%-5.15%-5.19%-19.01%-18.76%-6.22%0.82%11.01%1.81%5.71%4.19%6.52%0.33%-6.92%-1.9%-8.64%-8.36%-3.2%-27.46%-16.87%-54.09%-133.33%-160.97%-858.69%-8030.7%-70.18%
FCF Growth %-67.65%36.02%-10.85%68.31%-6.62%-228.79%-927.43%-89.04%601.08%-68.82%233.68%-26.42%2528.7%105.21%-400.48%72.1%-20.45%-284.97%79.74%-189.16%-7.13%-37.04%-24.94%25.81%-899.66%54.66%-
FCF per Share-0.22-0.17-0.27-0.24-0.78-0.76-0.250.030.330.050.180.350.510.02-0.43-0.10-0.40-0.36-0.10-0.50-0.21-0.23-0.18-0.21-0.94-0.11-1.13
FCF Conversion (FCF/Net Income)0.89x-0.05x-0.09x0.02x0.46x3.20x0.35x2.92x16.96x-45.55x-3.50x-2.52x8.35x1.10x-7.57x-0.06x0.62x0.67x0.10x0.78x5.34x0.90x0.80x0.99x0.65x0.01x0.18x
Interest Paid97K03.83M3.38M3.4M3.06M2.93M4.78M05.16M5.42M911K981K945K00661K0000000000
Taxes Paid00207K175K180K148K246K319K0284K290K25K177K17K0015K0000000000

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile quarterly cash generation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Cash Conversion Swings With Working Capital

Based on NEO's reported figures, operating cash flow ranged from -$25.3M to +$20.3M across the ten quarters, with OCF/NI ratios distorted by near-zero or negative net income denominators.

The OCF/NI ratio is largely uninterpretable here because net income was negative in most quarters, so the relationship between reported earnings and cash generation cannot be cleanly read from the ratio alone. The more informative pattern is that operating cash flow turned positive in several quarters even while GAAP net losses persisted, which suggests non-cash charges such as the $16M to $18M quarterly D&A and $8M to $12M SBC are carrying much of the earnings gap. Investors should monitor whether working capital swings, such as the -$28.0M change in 2026Q3, continue to drive quarterly OCF volatility.

Free Cash Flow Oscillates Around Breakeven

As reported in NEO's cash flow statements, free cash flow alternated between small positives and negatives, reaching $14.0M in 2025Q2 and -$29.8M in 2025Q1, with FCF margins spanning -17.8% to +7.7%.

The FCF profile shows no durable upward trajectory, with the strongest quarter, 2025Q2, appearing to reflect a favorable working capital inflow rather than a structural improvement in earnings power. Several quarters near zero FCF margin suggest the business is roughly self-funding at the operating line but has not yet demonstrated consistent surplus generation. This pattern warrants further investigation into whether recent quarterly gains are repeatable.

Capital Intensity Declining but Persistent

According to reported figures, CapEx as a share of revenue fell from 8.0% in 2024Q2 to 2.7% in 2026Q1 and 2.7% in 2025Q1, while D&A remained near $16M to $18M per quarter.

Capex intensity appears to have moderated substantially from the mid-2024 peak, which may indicate a shift from facility buildout toward a more maintenance-oriented spending profile. However, D&A running well above CapEx in recent quarters suggests the asset base is being depreciated faster than it is being replaced, a dynamic that could flatter near-term cash flow if sustained. Investors should monitor whether capex remains below depreciation over subsequent periods.

Working Capital Drains Dominate Recent Quarters

As reported in NEO's cash flow data, working capital consumed cash in most recent quarters, including -$28.0M in 2026Q3, -$19.2M in 2026Q1, and -$30.2M in 2025Q1, while releasing $14.0M in 2025Q2.

The recurring working capital outflows are the single largest driver of quarterly cash volatility and may indicate receivable build or inventory accumulation that is not yet reflected in earnings quality. Because the reported data does not break out receivables, inventory, and payables separately, the specific source of these drains cannot be confirmed from the supplied figures. Investors should monitor collection trends in future filings to assess whether these outflows reflect timing or a persistent cash absorption.

Cumulative Cash Gap Versus Reported Losses

Based on NEO's reported figures, cumulative net losses over the ten quarters total roughly -$196M, while cumulative operating cash flow is approximately -$6M, a gap of roughly $190M attributable largely to non-cash items.

The cumulative divergence suggests that the reported losses overstate the cash consumption of the operating business, with D&A and SBC accounting for a substantial portion of the difference over the period. This pattern may indicate that the business is closer to cash breakeven than its GAAP results imply, though the reliance on non-cash add-backs means the economic cost of equity compensation should not be ignored. Investors should monitor whether this gap narrows as operating losses shrink.

Non-Cash Add-Backs May Flatter Cash View

Based on reported figures, NEO's cash flow picture relies heavily on roughly $16M to $18M of quarterly D&A and recurring SBC, which may overstate underlying cash generation if these add-backs are treated as costless.

Stock-based compensation is added back in operating cash flow, yet it represents a real economic cost to shareholders through dilution, so a cash breakeven reading may understate the true cost of running the business. The quarterly D&A add-back is similarly large relative to reported capex, which suggests the cash profile could look better than the economic reinvestment need if the asset base requires replacement at higher cost over time. Investors should monitor whether operating cash flow remains positive once SBC and maintenance capex are considered together.

NEO — Frequently Asked Questions

Quick answers to the most common questions about buying NEO stock.

How much cash does NeoGenomics, Inc. (NEO) generate from operations?

NeoGenomics, Inc. (NEO) generated $5.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is NeoGenomics, Inc.'s free cash flow?

NeoGenomics, Inc. (NEO) reported negative free cash flow of $21.8M in 2025, indicating capital requirements exceeded cash from operations.

What is NeoGenomics, Inc.'s capital expenditure (CapEx)?

NeoGenomics, Inc. (NEO) spent $27.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.